|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-12-16
|
|
pubmed:abstractText |
Recombinant human soluble CD83 had previously exhibited significant immunosuppressive properties that involved interference with dendritic cell maturation in both mouse and humans, inhibition of autoimmunity in mice, and induction of antigen-specific mouse cardiac allograft tolerance when used in combination with other immunosuppressive drugs. Our current research focus turned to examining the effects of peritransplant soluble CD83 (sCD83) administration on prevention of chronic renal allograft rejection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/CD83 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloid Differentiation Factor 88,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1534-6080
|
|
pubmed:author |
pubmed-author:ArpJacquelineJ,
pubmed-author:BrandStephenS,
pubmed-author:CharltonBraydenB,
pubmed-author:DeBenedetteMarkM,
pubmed-author:GarciaBerthaB,
pubmed-author:HealeyDonD,
pubmed-author:LOY MYM,
pubmed-author:LianDamengD,
pubmed-author:LiuWeihuaW,
pubmed-author:NicoletteCharlesC,
pubmed-author:WangHaoH,
pubmed-author:ZhuLanL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1278-85
|
|
pubmed:meshHeading |
pubmed-meshheading:21079552-Adaptive Immunity,
pubmed-meshheading:21079552-Animals,
pubmed-meshheading:21079552-Antigens, CD,
pubmed-meshheading:21079552-Cyclosporine,
pubmed-meshheading:21079552-Cytokines,
pubmed-meshheading:21079552-Down-Regulation,
pubmed-meshheading:21079552-Graft Rejection,
pubmed-meshheading:21079552-Humans,
pubmed-meshheading:21079552-Immunity, Innate,
pubmed-meshheading:21079552-Immunoglobulins,
pubmed-meshheading:21079552-Immunosuppressive Agents,
pubmed-meshheading:21079552-Isoantibodies,
pubmed-meshheading:21079552-Kidney Transplantation,
pubmed-meshheading:21079552-Membrane Glycoproteins,
pubmed-meshheading:21079552-Mice,
pubmed-meshheading:21079552-Myeloid Differentiation Factor 88,
pubmed-meshheading:21079552-Rats,
pubmed-meshheading:21079552-Rats, Inbred F344,
pubmed-meshheading:21079552-Rats, Inbred Lew,
pubmed-meshheading:21079552-Recombinant Proteins,
pubmed-meshheading:21079552-Transplantation, Homologous
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prevention of chronic renal allograft rejection by soluble CD83.
|
|
pubmed:affiliation |
Department of Surgery, University of Western Ontario, London, ON, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
